TY - CHAP M1 - Book, Section TI - Cardiac Amyloid Imaging and 18F-FDG PET/CT for Imaging Sarcoidosis and Cardiovascular Infection A1 - Rosica, Dillenia A1 - Dorbala, Sharmila A2 - Heller, Gary V. A2 - Hendel, Robert C. PY - 2017 T2 - Nuclear Cardiology: Practical Applications, 3e AB - Cardiac amyloidosis, sarcoidosis, and cardiovascular infections are major causes of morbidity and mortality. Early diagnosis and timely application of specific therapy are critical to improve clinical outcomes.1,2 Echocardiography, cardiac magnetic resonance imaging (CMR), and cardiac CT can detect increased wall thickness, expanded extracellular volume, diffuse late gadolinium enhancement, wall motion abnormalities, fibrosis, vegetations, and abscesses resulting from cardiac amyloidosis, sarcoidosis, or infection. However, by the time the above cardiac structural changes are evident, the disease is at a fairly advanced stage. Moreover, some of these changes are nonspecific and may represent sequelae of other forms of heart diseases and are not disease specific. Radionuclide imaging methods are evolving as specific disease markers in amyloidosis, sarcoidosis, and infection imaging. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesscardiology.mhmedical.com/content.aspx?aid=1145444770 ER -